Morgan Stanley’s Axcella Health Inc. Common Stock AXLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,004
| Closed | -$10.5K | – | 8063 |
|
|
2023
Q3 | $10.5K | Hold |
1,004
| – | – | ﹤0.01% | 6719 |
|
|
2023
Q2 | $5.48K | Buy |
+1,004
| New | +$9.42K | ﹤0.01% | 6968 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 8006 |
|
|
2022
Q3 | – | Sell |
-28
| Closed | -$1.49K | – | 8002 |
|
|
2022
Q2 | $1K | Sell |
28
-38
| -58% | -$1.87K | ﹤0.01% | 7733 |
|
|
2022
Q1 | $4K | Sell |
66
-3
| -4% | -$150 | ﹤0.01% | 7659 |
|
|
2021
Q4 | $3K | Sell |
69
-1
| -1% | -$70 | ﹤0.01% | 7762 |
|
|
2021
Q3 | $5K | Sell |
70
-26
| -27% | -$2.23K | ﹤0.01% | 7508 |
|
|
2021
Q2 | $9K | Buy |
96
+90
| +1,500% | +$8.92K | ﹤0.01% | 7277 |
|
|
2021
Q1 | $1K | Sell |
6
-461
| -99% | -$65K | ﹤0.01% | 7405 |
|
|
2020
Q4 | $61K | Sell |
467
-486
| -51% | -$62.4K | ﹤0.01% | 6097 |
|
|
2020
Q3 | $110K | Buy |
953
+688
| +260% | +$84.8K | ﹤0.01% | 5385 |
|
|
2020
Q2 | $36K | Buy |
265
+236
| +814% | +$28.9K | ﹤0.01% | 5801 |
|
|
2020
Q1 | $2K | Sell |
29
-389
| -93% | -$39.9K | ﹤0.01% | 6420 |
|
|
2019
Q4 | $42K | Buy |
418
+397
| +1,890% | +$43.6K | ﹤0.01% | 5908 |
|
|
2019
Q3 | $3K | Sell |
21
-221
| -91% | -$40.9K | ﹤0.01% | 6446 |
|
|
2019
Q2 | $56K | Buy |
+242
| New | +$76.7K | ﹤0.01% | 5559 |
|
Other funds holding AXLA
Morgan Stanley's AXLA Position: Q4 2023 in Review
Morgan Stanley sold out of Axcella Health Inc. Common Stock (AXLA) in Q4 2023, closing a stake of 1,004 shares — an estimated $10.5K sold.
Morgan Stanley first reported a position in AXLA in Q2 2019 and held it in 15 quarters. The position peaked at $110K in Q3 2020. 1 fund tracked by Wall St. Rank holds AXLA as of Q4 2023.
- Morgan Stanley reported no remaining Axcella Health Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Morgan Stanley sold 1,004 Axcella Health Inc. Common Stock shares in Q4 2023, an estimated $10.5K.
- Morgan Stanley first reported a position in Axcella Health Inc. Common Stock in Q2 2019 and held it in 15 quarters.
- Morgan Stanley's Axcella Health Inc. Common Stock position peaked at $110K in Q3 2020.
- 1 fund tracked by Wall St. Rank held Axcella Health Inc. Common Stock as of Q4 2023.
Based on Morgan Stanley's 13F filing for Q4 2023, filed 13 Feb 2024.